What are the treatment options for eczema?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Eczema (Atopic Dermatitis)

Topical corticosteroids are the mainstay of treatment for eczema and should be your first-line therapy, applied no more than twice daily using the least potent preparation that controls symptoms. 1, 2

Core Treatment Algorithm

Step 1: Establish Foundation with Emollients and Skin Care

  • Apply emollients liberally and regularly as the cornerstone of maintenance therapy, even when eczema appears controlled 2
  • Apply emollients immediately after bathing to provide a surface lipid film that retards evaporative water loss from the epidermis 1, 2
  • Use dispersible cream as a soap substitute instead of regular soaps and detergents, which remove natural lipid from already-dry skin 1
  • Avoid alcohol-containing products 2
  • Keep nails short to minimize damage from scratching 1
  • Recommend cotton clothing next to the skin and avoid irritant materials like wool 1

Step 2: Initiate Topical Corticosteroids

Apply the basic principle: use the least potent preparation required to keep eczema under control, with short "steroid holidays" when possible. 1, 2

  • Apply topical corticosteroids once daily (not twice daily, as recent evidence shows once-daily application is equally effective) 3
  • Use very potent and potent corticosteroids with caution for limited periods only 1, 2
  • Stop topical corticosteroids when signs and symptoms (itching, rash, redness) resolve, or as directed 4
  • Consider the "get control then keep control" regimen for more aggressive disease management 3

Common pitfall to avoid: Patients' or parents' fears of steroids often lead to undertreatment—explain the different potencies and the benefits/risks clearly to improve adherence 1, 2

Step 3: Consider Topical Calcineurin Inhibitors for Sensitive Sites

  • Pimecrolimus (Elidel) is useful for sensitive sites where corticosteroid atrophy risk is higher (face, neck, flexures, genitals) 4, 3
  • Use only in patients age 2 years and older who do not have a weakened immune system 4
  • Apply a thin layer twice daily only to affected skin areas 4
  • Use for short periods with breaks in between; stop when symptoms resolve 4
  • Do not use continuously for long periods due to uncertain long-term safety profile 4
  • Most common side effect is burning or warmth at application site, typically mild and resolving within the first week 4

Step 4: Manage Secondary Infections Aggressively

Watch for deterioration in previously stable eczema—this may indicate secondary bacterial or viral infection. 1

For Bacterial Infection:

  • Look for increased crusting, weeping, or pustules 2
  • Prescribe flucloxacillin as first-line oral antibiotic for Staphylococcus aureus, the most common pathogen 1, 2
  • Use phenoxymethylpenicillin if β-hemolytic streptococci are isolated 1
  • Use erythromycin for flucloxacillin resistance or penicillin allergy 1
  • Continue topical corticosteroids during bacterial infection when appropriate systemic antibiotics are given concurrently 2

Critical pitfall to avoid: Do not delay or withhold topical corticosteroids when infection is present—they remain the primary treatment when appropriate systemic antibiotics are given 2

For Eczema Herpeticum (Medical Emergency):

  • Suspect if you observe grouped vesicles, punched-out erosions, or sudden deterioration with fever 1, 2
  • Initiate oral acyclovir early in the disease course 1, 2
  • Administer acyclovir intravenously in ill, feverish patients 1, 2

Step 5: Address Pruritus Selectively

  • Use sedating antihistamines only for short-term adjuvant therapy during severe pruritus relapses, primarily for their sedative properties to help with nighttime itching 1, 2, 3
  • Recommend nighttime use only; avoid daytime use 1
  • Large doses may be required in children 1
  • Do not prescribe non-sedating antihistamines—they have little to no value in atopic eczema 1, 2, 3

Evidence note: Recent high-quality evidence indicates oral antihistamines should be demoted from routine use, as there is little evidence to support their continued use 3

Step 6: Consider Adjunctive Tar Preparations

  • Ichthammol (1% in zinc ointment) is less irritant than coal tar and may be applied as ointment or paste bandages, particularly useful for healing lichenified eczema 1
  • Coal tar solution 1% in hydrocortisone ointment is adequate and does not cause systemic side effects unless used extravagantly 1

When to Escalate to Second-Line Treatments

Refer to specialist or escalate therapy if:

  • Failure to respond to moderate potency topical corticosteroids after 4 weeks 2
  • Need for systemic therapy or phototherapy 2
  • Suspected eczema herpeticum (medical emergency) 2

Second-Line Options (Specialist-Initiated):

Phototherapy:

  • Narrow band ultraviolet B (312 nm) is an option for phototherapy 1, 2
  • Some concern exists about long-term adverse effects such as premature skin aging and cutaneous malignancies, particularly with PUVA 1, 2

Systemic Immunosuppressants:

  • Dupilumab is the most effective biological treatment for moderate to severe eczema, more effective than placebo in achieving EASI75 (RR 3.04,95% CI 2.51-3.69) and improvement in POEM score at short-term follow-up 5
  • Dupilumab is associated with specific adverse events including eye inflammation and eosinophilia 5
  • Tralokinumab may be more effective than placebo in achieving short-term EASI75 (RR 2.54,95% CI 1.21-5.34), though evidence is of low certainty 5

Oral Corticosteroids (Use with Extreme Caution):

  • Systemic corticosteroids have a limited but definite role only for "tiding over" occasional patients during acute severe flares after all other treatment avenues have been explored 1, 2
  • Should never be used for maintenance treatment 1, 2, 6
  • Significant risk of pituitary-adrenal suppression, particularly with prolonged use 2
  • Corticosteroid-related mortality has been documented in other inflammatory conditions 2

Treatments to Avoid (Insufficient Evidence)

Do not routinely use the following, as recent evidence does not support their efficacy: 3

  • Oral or topical antistaphylococcal treatments for infected eczema (use systemic antibiotics only for overt infection)
  • Probiotics for treating eczema
  • Silk clothing
  • Ion-exchange water softeners
  • Emollient bath additives
  • Evening primrose oil 1

Avoid emollients from birth for prevention—large trials suggest they do not prevent eczema and may result in harms such as increased skin infections and food allergy 3

Monitoring and Follow-Up

  • Call patients back if symptoms get worse, skin infection develops, or symptoms do not improve after 6 weeks of treatment 4
  • Bacteriological swabs are not routinely indicated but may be necessary if patients do not respond to treatment 1
  • Maximum waiting time of 6 weeks for first specialist appointment if referral needed 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Eczema (Atopic Dermatitis)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Systemic treatments for eczema: a network meta-analysis.

The Cochrane database of systematic reviews, 2020

Research

Eczematous dermatitis: a practical review.

American family physician, 1996

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.